McCarthy summons GOP factions to counter threat of a new conservative rebellion
But several hard-right Republicans left the speaker's meeting less than satisfied, with several must-pass bills hanging in the balance.
Source: politico.com
📰 Study Chair News
Page 2 - Study Chair News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Study Chair. Real-time updates on events, politics, business and more.
CathWorks Announces First Patient Enrolled in Global ALL-RISE Study
Global clinical study aims to broaden evidence base by assessing clinical and economic benefits for the FFRangio System
United States Ajayj Kirtane Newyork Ramin Mousavi Cathworks Ffrangio Jason Weidman Presbyterian Columbia University Irving Medical Center
Source: dicardiology.com
CathWorks Announces First Patient Enrolled in Global ALL-RISE Study
/PRNewswire/ -- CathWorks announced today that the first patient has been enrolled in the Advancing Cath Lab Results with FFRangio Coronary Physiology...
Source: prnewswire.com
VITRAC Therapeutics to Present Phase 1 Clinical Trial Design on Novel Aurora Kinase A Inhibitor, VIC-1911, and G12C Inhibitor, Sotorasib, for KRAS G12C-Mutant Non-Small Cell Lung Cancer at the 2023 ASCO Annual Meeting
BOSTON--(BUSINESS WIRE)--Jun 4, 2023--
United States Mito Koya Sarah Goldberg Thomas Myers University Of Maryland Cancer Center Yale Cancer Center
Source: wsiltv.com
Immunitas Therapeutics Announces First Patient Dosed in Phase 1/2a Study of IMT-009
/PRNewswire/ -- Immunitas Therapeutics ("Immunitas"), a clinical stage precision immunotherapy company committed to discovering and developing novel,...
United States University School Amanda Wagner James Wooldridge Aeglea Biotherapeutics Melissal Johnson
Source: prnewswire.com
Santhera and ReveraGen Announce First Participant Dosed in FDA-funded Phase 2 Pilot Study with Vamorolone in Becker Muscular Dystrophy
Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc announce that the first patient has been dosed in a Phase 2 pilot study to assess vamorolone in Becker muscular dystrophy (BMD), funded by the U.S. Food and Drug Administration (FDA). This Phase 2 pilot study is a randomized, double-blind ...
Source: pharmiweb.com
Santhera Pharmaceuticals Holding AG: Santhera and ReveraGen Announce First Participant Dosed in FDA-funded Phase 2 Pilot Study with Vamorolone in Becker Muscular Dystrophy
Pratteln, Switzerland, and Rockville, MD, USA, August 22, 2022 - Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc announce that the first patient has been dosed in a Phase 2 pilot
Source: finanznachrichten.de
Jennifer Ayres receives top teaching award: 'Exemplary she has been, extraordinarily so'
She sets a standard for pedagogy at Candler School of Theology and across Emory. Exemplary Teacher of the Year Award recipient Jennifer Ayres focuses on “the full humanization of everyone in the classroom.”
Source: emory.edu
Cardior Pharmaceuticals: Cardior Appoints Cardiac Disease and RNA Drug Development Experts to its Scientific Advisory Board Supporting Pipeline Expansion in Both Large and Orphan Cardiac Indications
Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced the expansion of its Scientific Advisory
United Kingdom City Of United States David Crandall Johann Bauersachs Claudia Ulbrich Barbara Gaertner Rupprecht
Source: finanznachrichten.de
Cardior Appoints Cardiac Disease and RNA Drug Development Experts to its Scientific Advisory Board Supporting Pipeline Expansion in Both Large and Orphan Cardiac Indications
Cardior Appoints Cardiac Disease and RNA Drug Development Experts to its Scientific Advisory Board Supporting Pipeline Expansion in Both Large and Orphan Cardiac Indications - read this article along with other careers information, tips and advice on BioSpace
Source: biospace.com